The Translational Microbiome Research Forum
The Translational Microbiome Research Forum is an online resource for scientists engaged in translational microbiome research to access current, topical information and to provide a platform to exchange knowledge and ideas. We encourage you to participate by actively using the commenting system, by submitting events, and by joining our email list to receive updates when new content is posted.
Microbiomepost.com provides qualified scientific updates to healthcare professionals and to anyone who wants to know more about the microbiome.
Our mission is to tell the story of the microbiome by reporting the results of research carried out in laboratories all over the world with a journalistic style and a solid scientific basis. Bacteria have coexisted in our bodies for millions of years. They evolved with us in a sort of “peaceful” symbiosis. They are in the intestine, in the stomach, on the skin, in the lungs and beyond. We host about 100 billion microorganisms and they, in turn, synthesize different essential nutrients for us, take care of our immune system, protect us from their pathogenic “relatives”.
Research in this area began to take its first steps a few years ago and is therefore still in its infancy. The results however are already very interesting and cover nearly all medical disciplines, from gastroenterology to oncology, from dermatology to neuroscience.
According to some, we are living a real epochal turning point which could revolutionize the medical practice of the next decades.
And this is exactly the story we want to tell.
Rapid Microbiology is a well-established online resource for microbiologists worldwide, find the right products for your microbiology lab using our specially designed search functions. To keep up-to-date with the latest microbiology news get our free weekly newsletter which includes updates on products, services, webinars, training courses and conferences.
Pharma Phorum media is the premier digital publisher of thought leadership relating to the pharmaceutical industry. The news, opinions and insights published every day help industry executives better understand the broader healthcare landscape within which they operate, including regular contributions from their peers, innovative service providers, physicians, payers / policy makers, patient organisations and patients. Core channels include pharmaphorum.com, our new digital journal Deep Dive and a highly engaged social media audience through multiple platforms.
PharmaVOICE magazine reaches more than 46,000 BPA qualified subscribers and 60,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
Beneficial Microbes is a peer-reviewed scientific journal with a specific area of focus: the promotion of the science of microbes beneficial to the health and wellbeing of man and animal. The journal contains original research papers and critical reviews in all areas dealing with beneficial microbes in both the small and large intestine, together with opinions, a calendar of forthcoming beneficial microbes-related events and book reviews. The journal takes a multidisciplinary approach and focuses on a broad spectrum of issues, including safety aspects of pro- & prebiotics, regulatory aspects, mechanisms of action, health benefits for the host, optimal production processes, screening methods, (meta)genomics, proteomics and metabolomics, host and bacterial physiology, application, and role in health and disease in man and animal. Beneficial Microbes is intended to serve the needs of researchers and professionals from the scientific community and industry, as well as those of policy makers and regulators.